ArticleCanadian journal of anaesthesia = Journal canadien d'anesthesie2026
Association of a single low-dose intraoperative magnesium bolus with postoperative opioid requirements: a multicentre retrospective cohort study.
Article in Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeFew studies have investigated the effects of a low-dose, single magnesium bolus on postoperative pain. We sought to evaluate the association between an intraoperative bolus of 2 g magnesium iv and postoperative opioid consumption, with secondary outcomes focused on potential adverse effects.
methodsWe conducted a multicentre retrospective cohort study of adult patients from 14 hospitals in the northeastern USA who had received general anesthesia for elective surgery between 1 January 2018 and 31 December 2022. The primary outcome was total postoperative opioid consumption, defined as intravenous morphine milligram equivalents (IV MME) administered during the postanesthesia care unit (PACU) period. Secondary outcomes included PACU recovery time, levels of consciousness in the PACU, and intraoperative hemodynamics.
resultsAmong 257,206 patient encounters meeting inclusion criteria, 16,233 (6%) received a magnesium bolus. Of those, 95% were given a dose of 2 g iv. In adjusted models, magnesium was associated with increased postoperative opioid consumption (mean difference, 0.9 IV MME; 95% confidence interval [CI], 0.8 to 1.0; P < 0.001). No difference was observed in levels of consciousness in the PACU or in PACU recovery times. After magnesium administration, arterial blood pressure and heart rate decreased, with a gradual return to baseline and with small estimated absolute changes.
conclusionIntraoperative administration of a single bolus of 2 g magnesium iv was associated with a negligible change in postoperative opioid consumption and trivial hemodynamic effects. The results of this study suggest that a single low-dose magnesium bolus may offer no clinical benefit.
Indexed as
Identifiers
41894130What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.